Upcoming events
Information about upcoming CDT events.
CDT Seminar series, 27 April
Biomedical AI CDT Seminar series
Wednesday 27 April, 3pm
Title: Predicting the usage of healthcare services using neural networks and nationwide healthcare register data
Speaker: Pekka Marttinen, Aalto University.
Abstract: Accurately predicting the need for healthcare services is important, to allocate the limited resources fairly and efficiently. In this presentation I will introduce the problem of predicting future diagnoses and hospital visits using individual level trajectories of diagnoses and medical procedure codes available in electronic medical records. I will then present our recent work on developing neural networks for nationwide healthcare registers for this problem, to predict the usage of healthcare services by the elderly population in Finland. We show that by leveraging individual patient trajectories and modern neural network architectures, the prediction accuracy can be significantly improved compared to multiple strong baselines.
About the speaker: Pekka Marttinen is an associate professor in machine learning in the department of computer science at Aalto university, Finland. He received his PhD in Statistics at the University of Helsinki in 2008, and has been employed at Aalto since 2009, interleaved by periods as a visiting researcher at the Center for Communicable Disease Dynamics at Harvard and at the Sanger institute in Cambridge. He has received a Research Fellowship from the Academy of Finland. His research focuses on method development and modeling in machine learning, with emphasis on biomedical applications, and he has published 65 articles on these topics. He is best known for his work on scalable computational methods for detecting structure in massive genomic data sets and as well as for the development of Bayesian methodology for efficient and flexible modeling of complex and noisy data, including techniques such as likelihood-free inference and Bayesian neural networks.
CDT Seminar series, 11 May
Wednesday11 May, 4pm
Title: An Overview of Artificial Intelligence & Machine Learning at GlaxoSmithKline
Speaker: Kim Branson, GSK.
Dr Kim Branson is SVP Global Head of Artificial Intelligence and Machine Learning at the major pharmaceutical company GlaxoSmithKline and leads their drive to develop a data-first approach to drug discovery and development. The centre of this approach is to use AI/ML approaches with prior data from human genetics & functional genomics studies to transform the process by which novel drug candidates are discovered and maximise the likelihood of their leading to successful drugs. Kim will give an overview of GSKs adoption of AI/ML into their research culture, then dive deeper into some of the topics and invite questions from the audience to explore areas of common interest.